Major Depressive Disorder Clinical Trial
Official title:
IPS-MA - A Randomized Clinical Trial Examining the Effect of a Modified IPS Intervention in Addition to Treatment as Usual Versus Treatment as Usual Alone for Individuals With Mood or Anxiety Disorders
Verified date | July 2016 |
Source | Mental Health Centre Copenhagen |
Contact | n/a |
Is FDA regulated | No |
Health authority | Denmark: Danish Dataprotection Agency |
Study type | Interventional |
The aim of the present study, is to evaluate the effect of a supported employment
intervention, IPS-modified for people with mood and anxiety (IPS-MA) on employment or
education, when offered to people with onset mood or anxiety disorders who are not likely to
be able to return to work within three month.
The hypothesis is that the IPS-MA method is associated with a shorter recovery period and
more people returning to work or education, compared to treatment as usual.
Status | Completed |
Enrollment | 326 |
Est. completion date | July 2016 |
Est. primary completion date | March 2016 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 60 Years |
Eligibility |
Inclusion Criteria: - Diagnosed following the International Classification of Diseases (ICD-10) criteria of affective disorder (F30-39) or anxiety disorder (F40-41) - Not able to work within 3 months - Associated with the Mental Health Center Copenhagen, Frederiksberg, Hillerød, Hvidovre or Ballerup - Only having had contact to the Mental Health services during the past 3 years - Having had competitive employment or attending a study within the past two years. - Has returning to work or education as an important goal - Under the age of 60 - Able to speak, read and understand danish - Has given informed consent verbally and in writing Exclusion Criteria: - A somatic disease that effects the workability - Substance og alcohol abuse - have a guardian or a forensic psychiatric arrangement - not given informed consent |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor)
Country | Name | City | State |
---|---|---|---|
Denmark | Mental Health Center Ballerup, Mental Health Center Frederiksberg, Mental Health Center Copenhagen, and Mental Health Center of Northern Seeland | Ballerup |
Lead Sponsor | Collaborator |
---|---|
Mental Health Centre Copenhagen |
Denmark,
Bond GR, Drake RE, Becker DR. An update on randomized controlled trials of evidence-based supported employment. Psychiatr Rehabil J. 2008 Spring;31(4):280-90. doi: 10.2975/31.4.2008.280.290. Review. — View Citation
Campbell K, Bond GR, Drake RE. Who benefits from supported employment: a meta-analytic study. Schizophr Bull. 2011 Mar;37(2):370-80. doi: 10.1093/schbul/sbp066. Epub 2009 Aug 6. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Competitive employment or studying | Competitive employment includes being on rehabilitation benefits, flexible jobs and wage subsidy jobs. Information on employment and education will be extracted from the DREAM database. The database is administered by The National Labour Market Authority and contains information on employment, sickness leave, educations eligible to state education grant, pre-vocational training, disability pension, social security, and sickness benefits. | 12 months | No |
Other | Changing from matchgroup 2 or 3 to matchgroup 1 | If participants are matchgroup 2 or 3, they are not able to go back to work within the following 3 months. If participants are matchgroup 1, they should be actively seeking jobs. | 12 and 24 months | No |
Other | Number of days of competitive employment or studying | Information will be obtained from the Dream database. | 12 and 24 months | No |
Other | Time until returning to employment or education | Information will be obtained from the Dream database. | 24 months | No |
Other | Hamilton Rating Scale for Depression - 6 items | Level of symptoms of depression | 12 months | No |
Other | Hamilton Rating Scale for anxiety -6 item scale | Level of symptoms of anxiety | 12 months | No |
Other | The Bech-Rafaelsen Mania Scale (MAS) | Level of symptoms af mania | 12 and 24 months | No |
Other | Global Assessment of Function (GAF-F) | Level of function | 12 months | No |
Other | Personal and Social Performance (PSP) | Social performance in four domains (socailly usefull activities, personal and social relationships, self-care and disturbing and aggressive behaviour) | 12 and 24 months | No |
Other | WHO-5 well-being index | Level of health-related quality of life | 12 months | No |
Other | Sheehan Disability Scale (SDS) | Level of function regarding social relationships, work, spare time and family. | 12 and 24 months | No |
Other | The Empowerment Scale | 12 and 24 months | No | |
Other | The Changes Questionnaire | Motivation to seeking employment or education | 12 and 24 months | No |
Other | The Client Satisfaction Questionnaire | Satisfaction with treatment | 12 and 24 months | No |
Primary | Competitive employment or education | Competitive employment includes being on rehabilitation benefits, flexible jobs and wage subsidy job. Information on employment and education will be extracted from the DREAM database. This database is administered by The National Labour Market Authority and contains information on employment, sickness leave, educations eligible to state education grant, pre-vocational training, disability pension, social security, and sickness benefits. | 24 months | No |
Secondary | Number of days of competitive employment or studying | Information will be obtained from the Dream database. | 24 months | No |
Secondary | Hamilton Rating Scale for Depression - 6 items | Level of symptoms of depression | 24 months | No |
Secondary | Hamilton Rating Scale for anxiety -6 item scale | Level of symptoms of anxiety | 24 months | No |
Secondary | Global Assessment of Function (GAF-F) | Level of function | 24 months | No |
Secondary | WHO-5 well-being index | Level of health-related quality of life | 24 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05537558 -
Precision Medicine for the Prediction of Treatment (PROMPT) Response (PROMPT)
|
||
Terminated |
NCT02192099 -
Open Label Extension for GLYX13-C-202, NCT01684163
|
Phase 2 | |
Completed |
NCT03142919 -
Lipopolysaccharide (LPS) Challenge in Depression
|
Phase 2 | |
Recruiting |
NCT05547035 -
Identification of Physiological Data by a Wearable Monitor in Subjects Suffering From Major Depression Disorders
|
N/A | |
Terminated |
NCT02940769 -
Neurobiological Effects of Light on MDD
|
N/A | |
Recruiting |
NCT05892744 -
Establishing Multimodal Brain Biomarkers for Treatment Selection in Depression
|
Phase 4 | |
Recruiting |
NCT05537584 -
SMART Trial to Predict Anhedonia Response to Antidepressant Treatment
|
Phase 4 | |
Active, not recruiting |
NCT05061706 -
Multicenter Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
|
Phase 3 | |
Completed |
NCT04479852 -
A Study of the Safety and Efficacy of SP-624 in the Treatment of Adults With Major Depressive Disorder
|
Phase 2 | |
Recruiting |
NCT04032301 -
Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans
|
Phase 1 | |
Recruiting |
NCT05527951 -
Enhanced Measurement-Based Care Effectiveness for Depression (EMBED) Study
|
N/A | |
Completed |
NCT03511599 -
Cycloserine rTMS Plasticity Augmentation in Depression
|
Phase 1 | |
Recruiting |
NCT04392947 -
Treatment of Major Depressive Disorder With Bilateral Theta Burst Stimulation
|
N/A | |
Recruiting |
NCT05895747 -
5-HTP and Creatine for Depression R33 Phase
|
Phase 2 | |
Recruiting |
NCT05273996 -
Predictors of Cognitive Outcomes in Geriatric Depression
|
Phase 4 | |
Recruiting |
NCT05813093 -
Interleaved TMS-fMRI in Ultra-treatment Resistant Depression
|
N/A | |
Recruiting |
NCT05135897 -
The Neurobiological Fundaments of Depression and Its Relief Through Neurostimulation Treatments
|
||
Enrolling by invitation |
NCT04509102 -
Psychostimulant Augmentation of Repetitive TMS for the Treatment of Major Depressive Disorder
|
Early Phase 1 | |
Recruiting |
NCT06026917 -
Assessing Dopamine Transporter Occupancy in the Patients With Depression Brain With Toludesvenlafaxine Hydrochloride Extended-Release Tablets Using 11C-CFT Positron Emission Tomography (PET)
|
Phase 4 | |
Recruiting |
NCT06145594 -
EMA-Guided Maintenance TMS for Depression
|
N/A |